The fission yeast *Schizosaccharomyces pombe* provides an excellent model system for analysis of mechanisms of cell cycle regulation. In particular, genes involved in the G~2~/M transition and in progression through mitosis itself have been identified and studied extensively. Entry into mitosis depends upon *cdc2* gene function ([@B47]). Temperature-sensitive (ts)^1^ *cdc2* mutants arrest either exclusively at the G~2~/M boundary or at both the G~2~/M and G~1~/S boundaries ([@B46]). Likewise, temperature-sensitive *cdc13* and *cdc25* mutants arrest in G~2~ ([@B47]; [@B52]; [@B8], [@B9]; [@B24]). In contrast, temperature-sensitive mutations in *wee1* result in premature entry into mitosis ([@B43]; [@B62]; [@B45]; [@B53]). *wee1 mik1* double mutants undergo lethal, premature entry into mitosis, termed mitotic catastrophe ([@B33]). Genetic and biochemical analyses have elucidated the molecular mechanisms that lie behind the observed phenotypes. *cdc2* encodes a 34-kD protein serine/threonine kinase whose activity is required to drive progression into M phase ([@B25]; [@B61]). Cdc2p activity depends both upon its association with Cdc13p, a B-type cyclin ([@B8], [@B9]; [@B24]), as well as upon the balance between positive and negative regulatory phosphorylation events. Activation of Cdc2p requires phosphorylation at T167, while phosphorylation at Y15, mediated by the *wee1* and *mik1* gene products, inhibits the Cdc2p kinase activity ([@B19]; [@B20]; [@B14]; [@B33]; [@B32]). The *cdc25* gene product, a protein tyrosine phosphatase, dephosphorylates Cdc2 on Y15, activating the Cdc2p/ Cdc13p complex and allowing entry into mitosis (for review see [@B37]; [@B11]).

Progression through mitosis itself consists of a number of distinct processes. Early mitotic events in fission yeast include chromosome condensation, duplication of the spindle pole body (SPB; yeast equivalent of mammalian centrosome), and mitotic spindle formation. As cells progress through M phase, spindle elongation and chromosome segregation occur. Finally, septation and cytokinesis mark exit from mitosis. Just as genetic analyses first identified major players involved in coordinating entry into mitosis, analyses of mutant phenotypes have elucidated mechanisms of progression through mitosis. Temperaturesensitive cell untimely torn mutants (*cut*; [@B64]; [@B26]; [@B57]) define a number of genes involved in mitotic processes, particularly the processes of chromosome condensation and segregation. For example, in *cut1* ([@B69]), *cut2* ([@B69]; [@B17]), *cut3* ([@B54]), *cut14* ([@B54]), and *top2* ([@B64], [@B65]; [@B67]) mutants, spindle formation and elongation occur, but chromosomes fail to separate. Subsequently, a septum is layed down across the undivided nucleus to produce the characteristic cut phenotype. Cut1p and Cut2p interact physically; both gene products localize to the short mitotic spindle ([@B17],*b*). Although Cut1p levels remain constant throughout the cell cycle (Funabiki et al., 1996*b*), proteolysis of Cut2p must occur at the metaphase to anaphase transition to allow chromosome segregation ([@B17]). *cut3*, *cut14*, and *top2* are all required for proper chromosome condensation at mitosis. In *cut3*, *cut14*, and *top2* mutants, mitotic spindles form and elongate normally, but uncondensed chromosomal material fails to segregate ([@B64], [@B65]; [@B67]; [@B54]).

The *dis* mutants, like the *cut* mutants, display defects in chromosome segregation ([@B49]). In *dis1* mutants, chromosome condensation as well as spindle formation and elongation appear to occur normally. Nevertheless, sister chromatids fail to separate at anaphase B, upon elongation of the mitotic spindle ([@B49]; [@B41]). The *dis1* gene product, which displays no significant homology to previously characterized proteins, localizes to the mitotic spindle as well as to spindle pole bodies and cytoplasmic microtubules ([@B41]).

In addition to mutants defective in chromosome segregation, mutants defective in spindle formation and/or elongation have been isolated and define a second class of genes involved in progression through mitosis. Products of such genes include Sad1p, which localizes to spindle pole bodies ([@B23]); Nda2p and Nda3p, α1-tubulin, and β-tubulin, respectively ([@B63]; [@B68]; [@B73]); Cut7p, a putative kinesin-like mitotic motor protein ([@B21], [@B22]); Cut9p, Nuc2p, and Cut4p, *S. pombe* homologs of the *Saccharomyces cerevisiae* anaphase-promoting complex (APC) components CDC16, CDC23, and APC1, respectively, all of which are required for spindle elongation at the metaphase/anaphase transition ([@B27]; [@B60]; [@B56]; Yameshita et al., 1996; [@B75]); and Plo1p, the *S. pombe* homolog of the *Drosophila* polo kinase ([@B50]).

Finally, genes involved in the events that mark exit from mitosis, namely septation and cytokinesis, include many initially identified by virtue of septation-defective mutant phenotypes ([@B47]). In the septation-defective mutants (*cdc7*, *cdc11*, *cdc14*, and *cdc15*), septation and cytokinesis are blocked, but progression through the remainder of the cell cycle continues, such that cells elongate and accumulate multiple nuclei.

Interestingly, unlike *cdc2* or *cdc25* mutants ([@B47]), many of the mitotic mutants described above do not block all of the events of mitosis or lead to mid-mitotic arrest. Rather, these mutants illustrate the separability of the events of mitosis, both from one another and from progression through the remainder of the cell cycle. Thus, in *cut1*, *cut2*, *cut3*, *cut14*, and *top2* mutants, spindle elongation, septation, and, in the case of *cut1* and *top2*, entry into a subsequent cell cycle occur in the absence of chromosome segregation ([@B67]; [@B69]; [@B54]). Conversely, in *cdc7*, *cdc11*, *cdc14*, and *cdc15*, multiple rounds of mitosis occur without intervening rounds of septation and cytokinesis ([@B47]).

Here we describe the isolation and characterization of a temperature-sensitive *S. pombe* mutant, *dim1*-35. Like mutations in *cdc2* or *cdc25*, deletion of *dim1* from the genome blocks entry into mitosis. Unlike *cdc2* or *cdc25* mutants, however, hypomorphic *dim1*-35 mutant cells also display the ability to uncouple mitotic events. That is to say, *dim1*35 mutant cells incubated at restrictive temperature either arrest before entry into mitosis or proceed through mitosis and subsequent septation in the absence of proper chromosome segregation. Thus, *dim1* ^+^ defines a previously undescribed gene essential both for G~2~/M progression as well as for chromosome segregation in mitosis.

Materials and Methods
=====================

Yeast Methods, Strains, and Media
---------------------------------

*S. pombe* strains used in this study are listed in Table [I](#TI){ref-type="table"}. Strains were grown in yeast extract medium or minimal medium with appropriate supplements ([@B39]). Crosses were performed on malt extract medium ([@B39]) or glutamate medium (minimal medium lacking ammonium chloride and containing 0.01M glutamate, pH 5.6). Random spore analysis and tetrad analysis were performed as described ([@B39]). Double mutant strains were constructed and identified by tetrad analysis. Transformations were performed by electroporation ([@B51]). Genomic DNA was isolated as described ([@B39]; [@B28]).

*S. cerevisiae* strains used in this study are listed in Table [II](#TII){ref-type="table"}. Strains were grown in YPD (1% yeast extract, 2% bactopeptone, 2% glucose), YPGR (1% yeast extract, 2% bactopeptone, 1% raffinose, 1% galactose), SD (0.67% yeast nitrogen base, 2% glucose), or SGR (0.67% yeast nitrogen base, 1% raffinose, 1% galactose) with appropriate supplements. For the MET25 promoter, inducing conditions refer to growth on media lacking methionine; repressing conditions refer to growth on media containing 2.5 mM methionine. For the GALS promoter, inducing conditions refer to growth on YPGR or SGR plus appropriate supplements; repressing conditions refer to growth on YPD or SD plus appropriate supplements. Diploids were induced to sporulate on sporulation medium (1% potassium acetate, 0.1% yeast extract, 0.05% glucose, 2% bacto-agar). Transformations were performed by the lithium acetate method ([@B6]). Genomic DNA was isolated as described ([@B28]).

Plasmids and Molecular Biological Techniques
--------------------------------------------

Plasmids used in this study are listed in Table [III](#TIII){ref-type="table"}. All plasmid manipulations and bacterial transformations were by standard techniques ([@B55]). Essential features of plasmid construction are described below; details of plasmid construction are available from the authors upon request. All sequencing was performed using Sequenase 2.0 (USB, Cleveland, OH) according to manufacturer\'s instructions. All PCR reactions were performed using *Taq* DNA polymerase and the GeneAmp PCR reagent kit (Perkin Elmer, Norwalk, CT) in a PTC-100 programmable thermal controller (PTC-100; MJ Research, Watertown, MA) programmed as follows: 94°C, 1 min; 50°C, 2 min; 72°C, 2 min (40 cycles); 72°C, 10 min.

Isolation of the dim1-35 Mutant
-------------------------------

The temperature-sensitive strain *cdc2*-D217N (restrictive temperature, 36°C) was treated with the chemical mutagen nitrosoguanidine (NTG) as decribed ([@B39]). Cells mutagenized to 50% viability were plated on YE at a density of 300 colonies/plate and incubated at 27°C. Colonies were replica plated to 32°C. Colonies unable to grow at 32°C were picked and outcrossed extensively. Upon outcrossing of colony number 35, an extragenic ts mutation (restrictive temperature, 36.5°C) was observed to segregate away from *cdc2*-D217N. At 32°C, this mutant (later termed *dim1*-35) proved semiviable in a *cdc2* ^+^ background and lethal in a *cdc2*-D217N background. Hence, it was chosen for further characterization.

Physiological Experiments
-------------------------

For analysis of synchronous cell populations, 4 liters of cells were grown to midlog phase (8 × 10^6^ cells/ml) at permissive temperature (25°C) in YE medium. Cells were separated on the basis of size by centrifugal elutriation in an elutriator rotor (JE 5.0; Beckman Instr., Fullerton, CA). Cells synchronized in early G~2~ (i.e., the smallest cells in the population) were collected and inoculated into YE medium at 25 or 36°C. Synchrony was monitored at 20- to 25-min intervals by scoring 100 cells for the presence of a septum.

For nitrogen starvation and release experiments, cells were grown to midlog phase in rich medium at permissive temperature. Cells were collected by centrifugation, washed three times in minimal medium lacking nitrogen, and then inoculated into minimal medium lacking nitrogen. Cells were starved for nitrogen at permissive temperature for 19 h and then shifted to restrictive temperature. After 30 min at restrictive temperature, cells were collected by centrifugation and inoculated into rich medium (prewarmed to 36°C). Cultures were incubated at 36.5°C; samples were collected at 30-min intervals to monitor septation index, total cell number, viable cell number, cell morphology, and DNA content (see below).

For *dim1*-35 spore germination experiments, *dim1*-35 mutant spores were generated by mating KGY394 and KGY557 and then selecting for diploids on media lacking adenine. Diploid cells were allowed to sporulate. Sporulated diploids were collected and then treated with glusulase. Free spores were purified by centrifugation through 40% glucose. Purified spores were inoculated into rich medium and incubated at 36.5°C. Samples were collected at 1-h intervals to monitor septation index, total cell number, viable cell number, cell morphology, and DNA content of cells.

For analysis of the *dim1::his3* ^+^ terminal phenotype, KGY1180 and KGY1216 cells were grown in minimal medium (lacking thiamine) at 32°C. Cells in log phase growth were inoculated into YE medium (containing thiamine) and incubated at 32°C. Samples were collected at 1-h intervals to monitor total cell number, cell morphology, DNA content, and histone H1 kinase activity.

For determination of total cell number in the above experiments, cells were collected and fixed in 0.12 M NaCl, 3% formaldehyde, diluted appropriately, sonicated briefly, and then counted in triplicate using the Coulter^®^ Multisizer II (Coulter Electronics Limited, UK). Total cell number was taken as the average of each triplicate. For determination of viable cell number, cells collected at specified intervals were diluted appropriately, sonicated briefly, and then plated in triplicate onto appropriate media. For *S. pombe* cultures, cells were plated onto YE and incubated at 25°C. For *S. cerevisiae* GALS promoter shut off experiments, cells were plated onto YPGR and incubated at 32°C. After incubation, colonies were counted and viable cell number taken as the average of each triplicate. Total cell number and viable cell number were plotted on a linear scale; percent viability was taken as viable cells/ml divided by total cells/ml at each time point.

For analysis of thiabendazole (TBZ) sensitivity, *dim1*-35 or wild-type strains were streaked to YE agar containing 9 μg/ml TBZ dissolved in DMSO or an equivalent amount of DMSO alone. Plates were incubated at 29°C for 3 d. For analysis of TBZ sensitivity in liquid culture, cells were grown to mid-log phase in YE at 29°C. TBZ was added to cultures to a final concentration of 10 μg/ml. After 6 h, cells were collected, fixed with ethanol, and stained with DAPI (see below).

Flow Cytometry and Microscopy
-----------------------------

For flow cytometric analysis, cells were fixed in ice-cold 70% ethanol, washed in 50 mM sodium citrate, incubated with 0.1 μg/ml RNaseA in 50 mM sodium citrate for 2 h at 37°C, and then stained with 2 μg/ml propidium iodide in 50 mM sodium citrate at 4°C in the dark overnight. Cells were sonicated and analyzed by flow cytometry as described ([@B58]). All fluoresence microscopy was performed on a Zeiss microscope (Axioscope; Zeiss, Inc., Thornwood, NY) using appropriate filters. To visualize DNA, ethanol-fixed cells were washed in PBS and then stained with the fluorescent DNA-binding dye DAPI at 1 μg/ml. For immunofluorescence, cells were fixed in 70% ethanol at 4°C or in 100% methanol at −20°C for 8 min and then washed with PBS and processed as described ([@B39]). For staining of microtubules, fixed cells were incubated in a 1:10 dilution of the monoclonal TAT-1 primary antibody ([@B70]; a generous gift of Dr. K. Gull) followed by a 1: 100 dilution of Texas red--conjugated goat anti--mouse secondary antibody (Molecular Probes, Eugene, OR). For staining of spindle pole bodies, fixed cells were incubated in a 1:25 dilution of the polyclonal anti-Sad1p primary antibody ([@B23]; a generous gift of Dr. I. Hagan) followed by a 1:100 dilution of FITC-conjugated goat anti--rabbit secondary antibody (Molecular Probes).

Cloning and DNA Sequence of dim1
--------------------------------

*dim1*-35 mutant cells transformed with a pUR19-based *S. pombe* genomic library ([@B3]) were selected at 25°C on media lacking uracil and then replica plated to 36°C. Plasmids were recovered from 4 Ura^+^ Dim1^+^ colonies and analyzed by restriction digest and Southern blot analysis. Deletion constructs generated from rescuing plasmids were retransformed into *dim1*-35 to identify a minimal rescuing fragment. The minimal rescuing fragment was sequenced; sequence was analyzed for coding potential by comparison to sequences available in nucleic acid sequence databases accessible through the Baylor College of Medicine (Houston, TX) and the National Center for Biotechnology Information (Bethesda, MD).

For integration mapping, 3.7 kb of *dim1*-proximal genomic sequence encompassing the 2-kb minimal rescuing fragment was subcloned into the *S. pombe ura4*-based integrating vector pJK210 ([@B29]) to generate pKG695. pKG695 was linearized at the unique *Sac1* site within the *dim1* genomic fragment and the linearized plasmid transformed into the *dim1*-35 *ura4*-D18 mutant strain KGY698. Transformants were selected on media lacking uracil. Dim1^+^Ura^+^ transformants were picked and outcrossed to either *dim1* ^+^ or *dim1*-35 strains to verify cosegregation of the *dim1* ^+^ phenotype with the *ura4* ^+^ marker.

A putative full length *dim1* cDNA was isolated by PCR-mediated amplification from a pDB20-based *S. pombe* cDNA library ([@B16]) using the oligos 35START (5′-TCAGTTGATCATATGAGTTATTTTTTACC-3′) and 35STOP (5′-ATAAGCAAATGGATCCTTCTAGTAGCG-3′). PCR products were digested with *Nde*1 and *Bam*H1 and then subcloned into the *Nde*1 and *Bam*H1 sites of the *S. pombe* expression vector pMNS21L under control of the thiamine-repressible *nmt1* promoter ([@B34], [@B35]) to generate pKG709. Two independent subclones were sequenced to verify accurate PCR amplification of the appropriate cDNA. In the construction of all subsequent *dim1* cDNA-containing plasmids, pKG709 was utilized as the source of *dim1* cDNA, excised as an *Nde*1*/Bam*H1 fragment.

To determine the sequence of the *dim1*-35 allele, genomic DNA was isolated from the *dim1*-35 mutant strain KGY698. The *dim1*-35 gene was PCR amplified using the oligonucleotide primers 35START and 35STOP and subcloned into pMNS21L. Two independent subclones were sequenced.

Deletion of dim1 from the Genome and Analysis of Rescue by dim1^+^, CDH1, and mdim1 cDNAs
-----------------------------------------------------------------------------------------

To generate a deletion construct containing *dim1* genomic 5′ and 3′ flanking sequence but lacking *dim1* coding sequence, a 3-kb genomic fragment consisting of the *dim1* coding region plus ∼1-kb 5′ flank and 1.2-kb 3′ flank was subcloned into the plasmid pBS-SK^+^ (Stratagene, La Jolla, CA) to create pKG748. pKG748 was subjected to PCR amplification using the oligonucleotide primers 35Δ5′flank (5′-GCAATTCAGCTTCAGTTGATATAA) and 35Δ3′flank (5′-AGCCACCATTTGCTTATGCAAGAA). The PCR product was digested with *Hind*III and religated to create pKG916, in which the entire *dim1* coding region was replaced with a *Hind*III site. A 1.8-kb fragment encoding the *ura4* ^+^ gene or a 2.0-kb fragment encoding the *his3* ^+^ gene ([@B48]) was subcloned into pKG916 at the *Hind*III site to create pKG703 or pKG917, respectively. *Sac*1*/Hinc*II fragments consisting of *dim1* 5′ flank::*ura4* ^+^ (or *his3* ^+^)::*dim1* 3′ flank were isolated from pKG703 (or pKG917) and transformed into the diploid strains *dim1-35/dim1* ^+^ *his3-237/his3* ^+^ *ura4-D18/ura4-D18 leu1-32/leu1-32 ade6-M210/ade6-M216* (or *dim1-35/dim1* ^+^ *his3-D1/his3-D1 ura4-D18/ ura4-D18 leu1-32/leu1-32 ade6-M210/ade6-M216*). Ura^+^ (or His^+^) transformants were selected on media lacking uracil (or lacking histidine). Uracil prototrophs KGY833 and KGY841 and histidine prototrophs KGY1087 and 1088 were isolated, and genomic DNA was prepared and digested with *Hinc*II. *Hinc*II digests were separated by agarose gel electrophoresis, blotted to membranes, and hybridized with an α-\[^32^P\]dCTPlabeled, 700-bp *Sac*1*/Xba*1 fragment of *dim1* 5′ flank (see Fig. [3](#F3){ref-type="fig"}) to verify replacement of one allele of *dim1* with either the *ura4* ^+^ or *his3* ^+^ cassette in each diploid strain.

To test for rescue of putative *dim1::ura4* ^+^ or *dim1::his3* ^+^ mutants by the *dim1* cDNA, by a mouse *dim1* (*mdim1*) cDNA obtained from Genome Systems (these sequence data available from EMBL/GenBank/DDBJ under accession number W85636; clone ID number, 40729; Genome Systems ID number, CD4549; Genome Systems Inc., St. Louis, MO), or by the CDH1 cDNA PCR amplified from *S. cerevisiae* genomic DNA (see below), diploids carrying the *dim1::ura4* ^+^ or *dim1::his3* ^+^ deletions were transformed with LEU2- or *ura4*-based plasmids containing the cDNA of interest under control of the full strength *nmt1* promoter, the partially attenuated *nmt1*-T4 promoter, or the fully attentuated *nmt1*-T81 promoter in the pREP series of *S. pombe* expression vectors ([@B34], [@B35]; [@B4]; plasmids: pKG402, pKG709, pKG718, pKG815, pKG836, pKG897, pKG898, pKG901, pKG930, pKG931; see Table [III](#TIII){ref-type="table"}). Tranformants identified on selective media were allowed to sporulate. Spores were harvested by glusulase treatment of sporulated diploids ([@B39]) and plated on appropriate selective media to isolate the *dim1:: ura4* ^+^ or *dim1::his3* ^+^ haploids of interest. (*dim1::ura4* ^+^ haploids transformed with LEU2-based plasmids were selected on media lacking uracil and leucine; *dim1::his3* ^+^ haploids transformed with LEU2-based plasmids were selected on media lacking histidine and leucine; *dim1::his3* ^+^ haploids transformed with *ura4*-based plasmids were selected on media lacking histidine and uracil.) Lack of endogenous *dim1* sequence in putative deletion haploids rescued by plasmid-borne cDNAs was verified by Southern blot analysis. In brief, genomic DNA was isolated, digested with *Hinc*II, separated by agarose gel electrophoresis, blotted to membranes, and then hybridized with α-\[^32^P\]dCTP--labeled *dim1* cDNA or the 700-bp *Sac*1/*Xba*1 fragment described above.

To generate a *dim1::his3* ^+^ strain carrying a single integrated copy of *nmt1*-T81-*dim1* ^+^, the *dim1* cDNA was first subcloned as an *Nde*1/*Bam*H1 fragment into pREP81 to generate pKG815. The *nmt1*-T81-*dim1* ^+^ cassette was excised from pKG815 as a *Pst*1/*Bam*H1 fragment and subcloned into the *leu1*-based *S. pombe* integrating vector pJK148 ([@B29]) to generate pKG980. pKG980 was linearized at the unique *Nru*1 site within *leu1* and tranformed into KGY1090 (*dim1::his3* ^+^ carrying pKG898; see Table [II](#TII){ref-type="table"}). Leu^+^ transformants were selected on media lacking leucine and then streaked to media containing 1 mg/ml 5-fluoroorotic acid to evict the *ura4*-based pKG898 plasmid. A Leu^+^ Ura^−^ colony was isolated. Genomic DNA was prepared and analyzed by Southern hybridization as described above to verify lack of endogenous *dim1* sequence and integration of pKG980 in single copy at the *leu1* locus.

Isolation of a Putative Full Length CDH1 cDNA
---------------------------------------------

A full length CDH1 cDNA was PCR amplified from *S. cerevisiae* genomic DNA using the primers CDH1Start (5′-GAGTAAGAAGACTAGTTCATATGGCTAGTG-3′) and CDH1Stop (5′-CATAGTTATGTCGACTTATGAAAC-3′). PCR products were digested with the enzymes *Nde*1 and *Sal*1 or *Spe*1 and *Sal*1*. Nde*1/*Sal*1 fragments were subcloned into the *S. pombe* expression vector pMNS21L to generate pKG836; *Spe*1/*Sal*1 fragments were subcloned into the *S. cerevisiae* expression vector pRS415 GALS ([@B40]) to generate pKG837. For pKG836, one subclone, and for pKG837, two independent subclones were sequenced. All additional CDH1 cDNA constructs were generated using the CDH1 cDNA excised from pKG836 as an *Nde*1/*Sal*1 fragment or from pKG837 as a *Spe*1/*Sal*1 fragment.

Deletion of CDH1 and Analysis of Rescue of CDH1 by CDH1, dim1, and mdim1 cDNAs
------------------------------------------------------------------------------

A deletion construct consisting of the *S. cerevisiae* HIS3 gene flanked by 36 bp of genomic sequence 5′ of the CDH1 initiating ATG and 36 bp of sequence 3′ of the CDH1 stop codon was generated by PCR amplification of the HIS3 gene from the HIS3-based *S. cerevisiae* expression vector pRS313 ([@B59]) using the oligonucleotide primers CDH1KOStart (5′-ATAGTACGTAGAGAAAGAGTAAGAAGTCAAGTTTTGGCAGATTGTACTGAC-3′) and CDH1KOStop (5′-AGACATCGTGCGCCTAGCCTACATAGTTATTATGAACTCCTTACGCAT- CTG-3′). The PCR product was gel-purified and transformed into the diploid strain KGY823. Transformants were selected on media lacking histidine. The His^+^ transformant KGY937 was isolated, and genomic DNA was prepared. Genomic DNA was digested with *Hind*III and analyzed by Southern hybridization using the CDH1 cDNA and the *cdh1*::HIS3 deletion construct as probes, to verify replacement of one allele of the CDH1 coding region with the HIS3 gene.

To test for rescue of the *cdh1*::HIS3 mutant by CDH1, *dim1* ^+^, or mdim1, cDNAs under control of the heterologous MET25 or GALS promoter in the LEU2-based *S. cerevisiae* expression vector pRS415MET25 or pRS415GALS ([@B40]) were transformed into KGY937, and transformants were selected on media lacking leucine. (Plasmids tested for rescue: pKG837, pKG843, pKG849, pKG850, and pKG930; see Table [III](#TIII){ref-type="table"}) Transformants were induced to sporulate, and tetrads were dissected. His^+^ Leu^+^ colonies were identified by replica plating to media lacking histidine or leucine.

To generate strains carrying integrated copies of CDH1 or *dim1* under control of the MET25 or GALS promoter, promoter-cDNA cassettes were isolated from pRS415GALS or pRS415MET25 plasmid derivatives (pKG837, pKG843, pKG849, and pKG850; see Table [III](#TIII){ref-type="table"}) as *Sac*1/*Sal*1 fragments and subcloned into the *S. cerevisiae* integrating vector pRS405 ([@B59]). The resultant constructs (pKG912, pKG914, pKG913, and pKG911, respectively) were linearized at the unique *Eco*RV or *Bst*X1 site within the LEU2 gene, and linearized plasmids were transformed into KGY937. Putative integrants in the *cdh1*::HIS3 background were isolated as described above for isolation of *cdh1*::HIS3 haploids carrying a rescuing plasmid. Lack of endogenous CDH1 sequence and integration of rescuing constructs in single copy at the *leu2*-3,112 locus were confirmed by preparing genomic DNA from putative integrants, digesting DNA with *Xho*1 and *Hind*III, and subjecting digested DNA to Southern blot analysis using the CDH1 cDNA as a probe.

To generate Ubiquitin/N-degron--tagged versions of CDH1 and *dim1* ^+^ cDNAs under control of the GALS promoter, a Ubiquitin/N-degron tag was generated by PCR-mediated amplification of Ubiquitin encoding sequence from *S. cerevisiae* genomic DNA using the oligonucleotide primers UBIQ1 (5′-GCTCTAGAATGCAGATCTTTGTCAAGACTTTGACTGG-3′) and UBIQ2 (5′-GGACTAGTCATATGACCACTACCACCTCTCAATCTCAAGAC-3′). PCR products were subcloned into pBSSK^+^ (Stratagene, La Jolla, CA) to create pKG872. The Ubiquitin tag was removed from pKG872 as an *Xba*1/*Nde*1 fragment and cloned in frame upstream of either the CDH1 cDNA or the *dim1* ^+^ cDNA in pRS415 GALS, to generate pKG875 or pKG876, respectively. Integrating versions of GALS::UBCDH1 or GALS::UB*dim1* ^+^ (pKG882 or pKG903, respectively) were generated as described above, and *cdh1*::HIS3 haploids carrying integrated copies of GALS::UBCDH1 or GALS::UB*dim1* ^+^ were generated and verified as described above.

Histone H1 Kinase Assays
------------------------

For analysis of KGY1180 and KGY1216, lysates were prepared in HB buffer, and total cell lysates were assayed for histone H1 kinase activity as described ([@B38]). For temperature shift experiments, cells were grown in YE at permissive temperature (25°C) to mid-log phase, diluted in YE to 2 × 10^6^ cells/ml, and then shifted to restrictive temperature (36.5°C) for 4.5 h. Cells were pelleted, lysed with glass beads, and extracted with NP-40 buffer as described ([@B20]). Active Cdc2p/ Cdc13p complexes were immunoprecipitated from cell lysates by incubation with the anti-Cdc13p antibody GJG56 (DenHaese, G., and K.L. Gould, unpublished results), followed by incubation with protein A--Sepharose. Immunoprecipitates were washed extensively with NP-40 buffer and then split in two. One half of each immunoprecipitate was used as the source of histone H1-directed kinase activity in histone H1 kinase assays, as described ([@B20]). The second half was retained for use in Western blotting analysis to verify equal recovery of Cdc2 protein. Both kinase assays and untreated immunoprecipitates were resolved on 6 to 20% SDSPAGE gradient gels and then transferred to Immobilon-P (Millipore Corp., Bedford, MA). For detection of Cdc2p in the untreated immunoprecipitates, the blot was incubated consecutively with anti-Cdc2p antibody 4711 (1:10,000), alkaline phosphatase-conjugated goat anti--rabbit IgG (1:10,000; Molecular Dynamics, Sunnyvale, CA, and Amersham Life Science, Pittsburgh, PA), and enhanced chemifluorescence (ECF) detection reagents (Molecular Dynamics and Amersham Life Science), followed by chemifluorescence detection and quantitation using the Molecular Dynamics Storm^TM^ scanner. For quantitation of kinase activity, blots were exposed to phosphorimager screens (Molecular Dynamics) overnight and then phosphorylated histone H1 bands, visualized, and quantitated on a phosphorimager using MD ImageQuant Software Version 3.3 (Molecular Dynamics). For graphic presentation, histone H1 kinase activity was taken as phosphorylated histone H1 band intensity normalized to corresponding Cdc2p level, and kinase activity in the *dim1*-35 strain was assigned a value of one arbitrary unit, as the standard of comparison for all other strains.

Results
=======

dim1-35 Mutant Cells Fail to Segregate DNA Properly during Mitosis
------------------------------------------------------------------

In a screen for second site mutations that would reduce the restrictive temperature of the ts strain *cdc2*-D217N (see Materials and Methods), we isolated a recessive ts mutant, which we have named *dim1*-35 (for defective entry into mitosis). At the restrictive temperature of 36.5°C, *dim1*-35 mutant cells arrested with one of the following phenotypes: unequal division of DNA to daughter cells as judged by DAPI staining; DNA strung out along the length of a mitotic spindle, in either a *cut1/cut2*-like "archery bow" conformation ([@B69]) or a *top2/cut3/cut14*-like "φ" conformation ([@B54]); DNA "cut" by a medial septum laid down across the undivided nucleus; or a single undivided interphase nucleus (data not shown).

To characterize the arrest phenotype of *dim1*-35 more precisely, synchronized G~2~ populations of *dim1*-35 mutant cells or wild-type cells were inoculated into rich medium at 36.5°C. After inoculation, samples were collected at 20- to 25-min intervals to monitor septation index, total cell number, viable cell number, DNA content of cells, and cell and nuclear morphology. The results of these analyses are summarized in Fig. [1](#F1){ref-type="fig"}. In the *dim1*-35 mutant, the first peak of septation occurred at time 155 min. In contrast, in wildtype cells the first peak of septation occured 95 min after inoculation (Fig. [1](#F1){ref-type="fig"} *c*). At the first peak of septation, little loss of viability was observed in *dim1*-35 cells, and most cells maintained a 2C DNA content (Fig. [1](#F1){ref-type="fig"}, *a* and *d*). (The transient decrease in percentage of cells with 2C DNA content at the peak of septation presumably reflects the brief accumulation of daughter cells that have completed S phase of the next cell cycle while still adjoined at the septum, resulting in cells of apparent 4C DNA content.) DAPI staining revealed that cells passing through a first round of septation did not cut (Fig. [1](#F1){ref-type="fig"} *b*, *top*). At the end of the first peak of septation, cell number had approximately doubled, from 9 × 10^5^ to 16.3 × 10^5^ total cells/ml, suggesting that ∼80% of cells divided in the first cell cycle after shift to restrictive temperature.

In *dim1*-35, the second peak of septation occurred 145 min after the first peak of septation, in reasonable accord with wild-type cells in which the second peak of septation occurred 135 min after the first (Fig. [1](#F1){ref-type="fig"} *c*). Thus, *dim1*-35 cells were delayed relative to wild type in the first peak of septation but not in the second. In *dim1*-35, the second round of septation coincided with a significant loss of viability; viability began to decline rapidly just before septated cells were first observed in the population (i.e., late G~2~ and/or early M phases of the cell cycle) and continued to decline throughout the second round of septation (Fig. [1](#F1){ref-type="fig"} *c*). Flow cytometric analysis revealed a decrease in percentage of cells containing 2C DNA, with an accumulation of cells of greater or less than 2C DNA content (Fig. [1](#F1){ref-type="fig"} *d*). Consistent with flow cytometric analysis, DAPI staining revealed a cut phenotype or missegregation of DNA in ∼70% of septated cells at the second peak of septation (Fig. [1](#F1){ref-type="fig"} *b*, *middle*). At the end of the second round of septation, cell number had increased from 16.5 × 10^5^ to 25.4 × 10^5^ cells/ml, suggesting that ∼50% of cells divided in the second cell cycle. Thus, 50% of cells appeared not to enter a second round of mitosis and subsequent cell division. Consistent with the conclusion that 50% of cells failed to enter mitosis, 50% of cells maintained a 2C DNA content (Fig. [1](#F1){ref-type="fig"}, *a* and *d*), and ∼50% of cells appeared as single cells with an intact interphase nucleus, rather than as V-doublets in which gross missegregation or cutting of DNA had occurred (Fig. [1](#F1){ref-type="fig"} *b*, *bottom*; and data not shown).

In a separate experiment, *dim1*-35 cells synchronized by centrifugal elutriation were fixed and processed for immunostaining to examine both microtubules as well as the number of spindle pole bodies. No gross defects in SPB duplication, spindle formation, or spindle elongation were observed at either the first or the second mitosis, despite the failure of chromosomal material to segregate properly on the mitotic spindle at the second mitosis (Fig. [1](#F1){ref-type="fig"} *e*).

In summary, in a synchronous population of *dim1*-35 cells shifted to restrictive temperature, 80% of cells completed one round of mitosis; 20% of cells failed to divide in the first cell cycle after shift. Cells appeared to lose viability at or just before entry into a second round of mitosis (i.e., at the G~2~/M transition). Viability began to decline just before cells undergoing a second round of septation were observed and continued to decline throughout the second round of septation. These cells were unable to complete mitosis successfully. 50% of cells failed to enter mitosis, while in the 50% of cells that underwent a second round of mitosis, 70% "cut" or missegregated their DNA, resulting in accumulation of cells of non-2C DNA content (Fig. [1](#F1){ref-type="fig"}).

In the Absence of Septation and Cutting, the dim1-35 Mutation Blocks Multiple Rounds of Nuclear Division
--------------------------------------------------------------------------------------------------------

In the synchronous block described above, the *dim1*-35 mutant shifted to restrictive temperature lost viability just before development of a "cut" phenotype in septated cells. We wished to determine what effect the *dim1*-35 mutation might have in the absence of septation. To answer this question, we made use of the *cdc11*-119 mutant. *cdc11*-119 cells shifted to the restrictive temperature of 36°C fail to make septa but rather undergo repeated rounds of nuclear division without septation, accumulating multiple nuclei in each cell ([@B47]). A *dim1*-35 *cdc11*-119 double mutant was constructed, and the double mutant strain examined after shift to restrictive temperature, in comparison to *cdc11*-119 alone. As expected, *cdc11*-119 cells elongated and accumulated multiple nuclei. *dim1*-35 *cdc11*-119 cells elongated to a comparable extent but failed to accumulate more than two nuclei per cell (Fig. [2](#F2){ref-type="fig"}, *a* and *b*). Binucleate cells did accumulate in both *cdc11*-119 single and *dim1*-35 *cdc11*-119 double mutant cells, although accumulation of binucleate cells was somewhat delayed in *cdc11*119 *dim1*-35 as compared to *cdc11*-119 (Fig. [2](#F2){ref-type="fig"} *b*). During the remaining 4 h at restrictive temperature, *cdc11*-119 single mutants went on to accumulate four and eight nuclei/ cell, while the majority of *dim1*-35 *cdc11*-119 double mutants remained binucleate (Fig. [2](#F2){ref-type="fig"} *b*). (Note that in the *cdc11*-119 *dim1*-35 double mutant, ∼20% of cells remained uninucleate throughout the time course of the experiment; at later time points, up to 20% of cells leaked through the apparent *dim1*-35 block to accumulate three or four nuclei/cell.) Thus, consistent with the behavior of the *dim1*-35 single mutant, the *dim1*-35 mutation in the absence of septation allowed a single, delayed round of nuclear division in ∼80% of cells at restrictive temperature but blocked subsequent nuclear division in the majority of cells.

Given the arrest phenotype of *cdc11*-119 *dim1*-35 mutant cells as binucleates, we wished to ask whether the *dim1*-35 mutation resulted in failure to enter a second round of mitosis, in an arrest during the second round of mitosis itself, or in failed nuclear division despite entry into mitosis. To address the possibility of a mid-mitotic arrest, *cdc11*-119 and *cdc11*-119 *dim1*-35 mutants were incubated at restrictive temperature for 5 h, at which point *cdc11*-119 *dim1*-35 cells had reached the terminal arrest phenotype, with ∼20% of cells arrested as uninucleates and ∼70% arrested as binucleates (Fig. [2](#F2){ref-type="fig"} *b*). At hourly intervals after shift to restrictive temperature, cells were collected, fixed, and processed for immunostaining. Throughout the time course, the majority of cells in both *cdc11*-119 and *cdc11*-119 *dim1*-35 mutants contained interphase nuclei with uncondensed chromatin, an interphase array of microtubules, and a single SPB per nucleus (Fig. [2](#F2){ref-type="fig"} *d* and data not shown). In both populations, however, there was evidence of continuing passage through M phase; in either population, 5 to 7% of cells at each time point contained a mitotic spindle and/or duplicated SPBs (data not shown). By these criteria, the *dim1*-35 mutation did not lead to midmitotic arrest, although some cells continued to pass through M phase, with or without segregation of DNA (see below and Discussion).

In the synchronous shift experiment described above, accumulation of cells of greater than 2C DNA content was observed (Fig. [1](#F1){ref-type="fig"}, *a* and *d*). Accumulation of polyploid DNA content suggested that cells that failed to segregate DNA properly during mitosis nevertheless entered S phase of a subsequent cell cycle. We wished to determine whether *cdc11*-119 *dim1*-35 cells likewise entered subsequent cell cycles after proceeding through mitosis without segregation of DNA. *cdc11*-119 *dim1*-35 cells shifted to restrictive temperature were collected and fixed for flow cytometric analysis. In *cdc11*-119, peaks of DNA content rose and fell coincident with peaks of nuclear content; peaks of 1, 2, and 4 nuclei/cell reached a maximum just before peaks of 2C, 4C, and 8C DNA, respectively (Fig. [2](#F2){ref-type="fig"}, *b*, *c*, and *e*, *left graphs*). In contrast, *cdc11*-119 *dim1*-35 double mutants accumulated a significant population of cells of 8C DNA content by 7 h after shift to restrictive temperature, despite the fact that *cdc11*-119 *dim1*-35 double mutant cells remained predominantly binucleate from the 4 h time point on (Fig. [2](#F2){ref-type="fig"}, *b*, *c*,and *e*, *right graphs*).

Consistent with the hypothesis that at least a subpopulation of *cdc11*-119 *dim1*-35 mutant cells entered and completed mitosis without DNA segregation, trinucleate cells were observed at some frequency in the *cdc11*-119 *dim1*35 population. Of the 20% of *cdc11*-119 *dim1*-35 cells that leaked through the *dim1*-35 block to accumulate greater than 2 nuclei/cell, 50% contained three rather than four nuclei, suggesting a failure of nuclear division in one of two nuclei despite entry into M phase (Fig. [2](#F2){ref-type="fig"} *f*, see Discussion).

In Nitrogen Starvation and Release Experiments, dim1-35 Cells Display a First Cell Cycle Arrest
-----------------------------------------------------------------------------------------------

As described above, in synchronous shift experiments as well as in the *dim1*-35 *cdc11*-119 double mutant, the *dim1*35 mutation produced a second cell cycle arrest phenotype. Therefore, we considered the possibility that the *dim1* gene product may play a role in S phase. According to this hypothesis, cells in G~2~ shifted to restrictive temperature would complete one round of mitosis successfully but would fail at the second mitosis due to defects that occur upon passage through S phase at restrictive temperature. To test this hypothesis, we performed both nitrogen starvation/release as well as spore germination experiments. In nitrogen starvation/release experiments, *dim1*-35 cells were starved for nitrogen at permissive temperature to accumulate cells in G~1~, incubated at restrictive temperature for 30 min to initiate inactivation of the temperaturesensitive Dim1-35p, and then released into rich medium at restrictive temperature. Samples were collected at 30-min intervals to monitor septation index, viability, cell morphology, and DNA content. As shown in Fig. [3](#F3){ref-type="fig"}, cells reentered the cell cycle and accumulated 2C DNA with little loss in viability. Viability then began to decline just before septated cells were first observed in the population (i.e., coincident with late G~2~ and/or early M phases of the cell cycle; Fig. [3](#F3){ref-type="fig"} *b*). As in the synchronous shift experiments described above, loss of viability was followed by a loss of 2C DNA content, as cells cut or missegregated their DNA (Fig. [3](#F3){ref-type="fig"}).

In spore germination experiments, *dim1*-35 spores were inoculated into rich medium at restrictive temperature and samples collected for analysis at hourly intervals. Similar to the results of the nitrogen starvation/release experiment, spores were able to germinate and pass through G~1~/S, as evidenced by the accumulation of cells with 2C DNA content (data not shown). Again, loss of viability occurred coincident with late G~2~/early M; viability began to decline just before the appearance of septated (cut) cells (data not shown). Thus, in both nitrogen starvation/release and spore germination experiments, a first cell cycle arrest occurred, suggesting the possibility that the G~2~/M phenotype observed in *dim1*-35 may be the result of S phase defects. More likely, however, the first cell cycle arrest in these experiments reflected the length of time spent at restrictive temperature before entry into the first mitosis: ∼85 min in the synchronous shift, ∼3.5 h in the nitrogen starvation/release experiment, and ∼7 h in the spore germination experiment (Figs. [1](#F1){ref-type="fig"} and [3](#F3){ref-type="fig"}; see Discussion).

dim1 Encodes a Highly Conserved Predicted Polypeptide of 142 Amino Acids
------------------------------------------------------------------------

To explore the molecular basis of the *dim1*-35 phenotype in greater detail, as well as to determine the phenotype of a *dim1* null allele, we cloned the *dim1* gene by complementation of the *dim1*-35 mutant phenotype. A pUR19-based *S. pombe* genomic library ([@B3]) was transformed into the *dim1*-35 mutant strain. Four genomic clones that allowed growth of *dim1*-35 at 36°C were recovered and shown by restriction digest and Southern blot analysis to contain overlapping fragments. A minimal rescuing fragment of 2 kb was identified (Fig. [4](#F4){ref-type="fig"} *a*) and sequenced to reveal a single coding region consisting of five exons separated by four introns, each containing perfect 5′ splice, 3′ splice, and branch site consensus sequences ([@B76]; Fig. [4](#F4){ref-type="fig"} *b*).

That the rescuing gene encoded *dim1* ^+^ and not a high copy suppressor was confirmed by integration mapping. pKG695, containing 3.7 kb of rescuing DNA and the selectable *ura4* ^+^ marker was linearized within the *dim1* 5′ flanking sequence and integrated into the genome of the *dim1*-35 *ura4*-D18 strain KGY698 by homologous recombination. In outcrosses of the integrant strain to either wild type or *dim1*-35, the *ura4* ^+^marker segregated with a *dim1* ^+^ phenotype in 26 out of 26 tetrads analyzed, confirming that the rescuing DNA had integrated adjacent to the *dim1*-35 locus.

That the rescuing gene consisted of the five identified exons and not another gene contained within the rescuing DNA fragment was confirmed by designing oligonucleotide primers for PCR-mediated amplification of the corresponding cDNA from an *S. pombe* cDNA library. Amplification generated a PCR product of predicted size. The PCR product was subcloned into the *S. pombe* expression vector pMNS21L under control of the thiamine-repressible *nmt1* promoter. Two independent subclones were sequenced. Sequence of the cDNA confirmed the previously determined sequence of the genomic clone and verified the predicted intron/exon boundaries; no errors were found in the PCR amplification products. Plasmids carrying the *dim1* cDNA were transformed into *dim1*-35 mutant cells and shown to rescue the mutant phenotype, thus confirming the identity of the rescuing gene as *dim1* (data not shown).

Finally, genomic DNA was prepared from the *dim1*-35 mutant strain, and the primers described above were utilized to amplify the *dim1*-35 gene. The PCR product was subcloned, and two independent subclones were sequenced. Sequence analysis revealed a single mutation in nucleotide 644 (G to A), producing a single amino acid change (G126D; see Fig. [4](#F4){ref-type="fig"} *b*). By all of the above criteria, we have cloned the *dim1* gene.

A search of the databases revealed that *S. pombe dim1* shares extensive homology with expressed sequence tags (ESTs) isolated from a number of other eukaryotic species, from budding yeast to human (Fig. [4](#F4){ref-type="fig"} *c*). None of these ESTs has been characterized; as described in greater detail below, we show here that both *S. pombe dim1* and the *S. cerevisiae dim1* homolog (CDH1 for *Saccharomyces cerevisiae dim1* homolog) are essential genes; that mouse *dim1* (*mdim1*) can functionally complement *S. pombe dim1*; and that both *S. pombe dim1* and mouse *dim1* can functionally complement a null mutation in CDH1.

S. pombe dim1 Is an Essential Gene; the dim1 Deletion Mutant Displays Characteristics of G~2~ Arrest
----------------------------------------------------------------------------------------------------

To determine whether *dim1* encodes an essential gene, we used the method of one step gene disruption to replace one copy of the *dim1* coding region with either the *ura4* ^+^ or *his3* ^+^ selectable marker in diploids heterozygous for the *dim1*-35 mutation (Fig. [5](#F5){ref-type="fig"} *a*). Replacement of one allele of *dim1* with the *ura4* ^+^ cassette or the *his3* ^+^ cassette in putative deletion strains (putative *ura4* ^+^ deletions: KGY 833 and KGY 841; putative *his3* ^+^ deletions: KGY1087 and KGY 1088) was confirmed by Southern blot analysis (data not shown). Diploids were allowed to sporulate, and tetrads were dissected. In all cases, tetrads segregated two viable: two inviable progeny. In all tetrads, the inviable segregants germinated and underwent up to two residual cell divisions before arresting as slightly elongated cells (Fig. [5](#F5){ref-type="fig"} *b*). For KGY 833, all viable segregants formed colonies of Ura^−^Dim1^ts^ cells, and for KGY 1087, all viable segregants formed His^−^Dim1^ts^ colonies, confirming replacement of the *dim1* wild-type allele in KGY 833 and KGY 1087. For KGY 841, all viable segregants formed Ura^−^Dim1^+^ colonies, and for KGY 1088, all viable segregants formed His^−^Dim1^+^ colonies, verifying replacement of the *dim1*35^ts^ allele in KGY 841 and 1088. As final confirmation for deletion of the *dim1* gene in KGY 833, 841, 1087, and 1088, various constructs carrying the *dim1* ^+^ cDNA under control of the thiamine-repressible *nmt1* promoter were shown to rescue the lethality of the putative *dim1*::*ura4* ^+^ and *dim1*::*his3* ^+^ mutants, in the presence or absence of thiamine, after transformation and sporulation of diploids (Fig. [5](#F5){ref-type="fig"}, *c* and *d*; and data not shown). Thus, the lethal deletions in KGY 833, 841, 1087, and 1088 had occurred at the *dim1* locus; *dim1* encodes an essential gene in *S. pombe.* These experiments further demonstrated that overexpression of *dim1* ^+^ had no toxic or deleterious phenotypic consequences. As shown in Fig. [4](#F4){ref-type="fig"} (*c* and *d*), cells overexpressing *dim1* ^+^ from the full strength *nmt1* promoter (KGY842) grew and divided normally. (Overproduction of Dim1p in these cells was verified by Western blot analysis using polyclonal α-Dim1p antibodies; data not shown.)

The fact that *dim1::ura4* ^+^ or *dim1::his3* ^+^ spores germinated and underwent up to two residual cell divisions complicated analyses of the terminal null phenotype. Therefore, a *dim1::his3* ^+^ strain carrying a single integrated copy of *nmt1-*T81 integrated at the *leu1-32* locus (KGY1180) was generated. Although multicopy *nmt1*-T81::*dim1* ^+^ rescued *dim1::his3* ^+^ lethality in either the absence or presence of thiamine (Fig. [5](#F5){ref-type="fig"}), KGY1180 proved viable in the absence of thiamine but not in the presence of thiamine (data not shown). To examine the terminal phenotype of KGY1180, cells were grown to mid-log phase in minimal medium lacking thiamine and then shifted to rich medium containing thiamine. Samples were collected hourly after shift. In the first 6 to 7 h after shift, cell number continued to double approximately once every 3 h, with kinetics identical to those of the isogenic wild-type control KGY1216 (*dim1* ^+^ *nmt1*-T81::*dim1* ^+^; Table [I](#TI){ref-type="table"}). By 8 to 10 h after shift, however, cell number began to level off, and by 13 h after shift, cells had ceased to divide, indicating that cells had reached a terminal phenotype (Fig. [6](#F6){ref-type="fig"} *a*). At the 13-h time point and throughout the time course, cells maintained a 2C content of DNA (Fig. [6](#F6){ref-type="fig"} *b*). Moreover, by 13 h after shift, cells had elongated moderately, contained interphase nuclei, and displayed an interphase array of microtubules, all suggestive of G~2~ arrest (Fig. [6](#F6){ref-type="fig"} *c*). Biochemical data were consistent with the morphological evidence of G~2~ arrest; the KGY1180 mutant did not arrest with elevated levels of histone H1 kinase activity as compared to KGY1216. Indeed, histone H1 kinase activity in KGY1180 was approximately half that of KGY1216 both in the absence and presence of thiamine (data not shown). In short, the terminal phenotype of the *dim1* deletion mutant gives no indication of entry into M phase, suggesting that *dim1* ^+^ is required for entry into mitosis and that the mitotic phenotypes observed in *dim1*-35 result from the "leaky" nature of the *dim1* allele (see Discussion).

Mouse dim1 (mdim1) Rescues Lethality of the dim1 Deletion Mutant
----------------------------------------------------------------

Given the high degree of sequence homology between *dim1* and a number of ESTs listed in the databases, we wished to determine whether *dim1* may be functionally conserved across the eukaryotic lineage. To this end, oligonucleotide primers were designed to PCR amplify the *S. cerevisiae* homolog of *dim1* (CDH1) from *S. cerevisiae* genomic DNA. In addition, the mouse homolog of *dim1* (*mdim1*) was obtained from Genome Systems Inc. (St. Louis, MO). Both CDH1 and *mdim1* clones were sequenced to confirm their identities and then subcloned into the *S. pombe* pREP series of expression vectors to test for ability to rescue the ts defect of *dim1*-35 and/or the lethal phenotype of the *dim1* deletion.

Driven by either the full strength *nmt1* promoter or the partially attenuated *nmt1*-T4 promoter, *mdim1* rescued *dim1*-35 in the absence of thiamine (promoter induced) but not in the presence of thiamine (promoter repressed). *mdim1* under control of the fully attenuated *nmt1*-T81 promoter failed to rescue *dim1*-35 in the absence or presence of thiamine (data not shown). Requirements for rescue of a *dim1* null allele appeared somewhat more stringent; *mdim1* rescued *dim1::ura4* ^+^ (or *dim1::his3* ^+^) only under control of the full strength *nmt1* promoter and only in the absence of thiamine (Fig. [5](#F5){ref-type="fig"}, *c* and *d*).

In contrast to *mdim1*, CDH1 failed to rescue *dim1*-35 or *dim1::ura4* ^+^ under control of any one of the three variable-strength *nmt1* promoters, in the absence or presence of thiamine. Indeed, overexpression of CDH1 in the *dim1*35 mutant proved toxic. *dim1*-35 mutant cells carrying either multi-copy *nmt1*::CDH1 or an integrated copy of *nmt1*::CDH1 were unable to form colonies on media lacking thiamine at either 29° or 25°C, temperatures fully permissive for growth of *dim1*-35 (data not shown). In a *dim1* ^+^ background, overexpression of CDH1 was not lethal, although cells grew slowly and poorly, with a slightly elongated morphology (data not shown).

The S. cerevisiae Homolog of dim1 (CDH1) Is an Essential Gene; Both S. pombe dim1 and Mouse dim1 Rescue a Null Mutation in CDH1
-------------------------------------------------------------------------------------------------------------------------------

To further investigate functional conservation among *dim1* homologs, we chose to generate a null allele of *S. cerevisiae* CDH1. By the method of one step gene disruption, one copy of the CDH1 coding region was replaced with the selectable marker HIS3 in the diploid strain KGY823. Replacement of one allele of CDH1 in the putative deletion strain KGY937 was confirmed by Southern blot analysis (data not shown). KGY937 was induced to sporulate, and tetrads were dissected. 24 out of 24 tetrads segregated two viable to two inviable progeny. Inviable segregants germinated and formed microcolonies of ∼4 to 30 cells before arresting (data not shown). All viable colonies were His^−^. Thus, CDH1 encodes an essential gene in *S. cerevisiae.*

CDH1, *dim1* ^+^, or *mdim1* cDNAs under control of the inducible MET25 or GALS promoters were tested for the ability to rescue the *cdh1*::HIS3 mutant when carried on multi-copy plasmids or integrated into the genome in single copy. Single integrated copies of MET25::CDH1, GALS::CDH1, MET25:: *dim1* ^+^, or GALS::*dim1* ^+^ were capable of rescuing the *cdh1*::HIS3 mutant under either repressing or inducing conditions for the heterologous MET25 or GALS promoters (Fig. [7](#F7){ref-type="fig"}, *a* and *b*, and data not shown). In the case of *mdim1*, rescue of *cdh1*::HIS3 was achieved only when GALS::*mdim1* was carried on a multicopy plasmid (pKG900) and only under inducing conditions for the GALS promoter (Fig. [7](#F7){ref-type="fig"}, *a* and *b*).

cdh1::HIS3 Cells Accumulate and Arrest with a G~2~/M Content of DNA
-------------------------------------------------------------------

To examine the phenotype of the cdh1::HIS3 mutant in greater detail, we wished to create a system for conditional expression of CDH1 function. As described above, repression of the heterologous MET25 or GALS promoters was not sufficient to abrogate rescue of *cdh1*::HIS3 by single integrated copies of MET25::CDH1, GALS::CDH1, MET25::*dim1* ^+^, or GALS:: *dim1* ^+^. (At the time of these experiments, the *mdim1* clone was unavailable.) Therefore, we made use of the Ubiquitin/N-degron tagging strategy described by Althoeffer et al. (1995). Under repressing conditions, a single integrated copy of a cDNA encoding a Ubiquitin/N-degron--CDH1 fusion protein driven by the GALS promoter (GALS::UBCDH1) still allowed growth, albeit poor growth, of the *cdh1*::HIS3 mutant (Fig. [7](#F7){ref-type="fig"} *a*). In contrast, a single integrated copy of GALS:: UB*dim1* ^+^ rescued under inducing conditions but failed to rescue under repressing conditions for the GALS promoter (Fig. [7](#F7){ref-type="fig"} *a*). Therefore, we utilized strain KGY1023 (*cdh1*::HIS3 carrying GALS::UB*dim1* ^+^ integrated in single copy; Table [II](#TII){ref-type="table"}) to examine the null phenotype of *cdh1.*

KGY1023 or wild-type strain KGY820 was grown to mid-log phase at 32°C in synthetic complete medium containing 1% galactose/1% raffinose as the sole carbon source (SGR medium) to induce expression of GALS:: UB*dim1* ^+^. At time 0, cells were washed three times in synthetic complete medium containing 2% glucose (SD medium) to repress expression of pGALS::UB*dim1* ^+^ and then resuspended in SD medium and incubated at 32°C. At hourly intervals, samples were collected for determination of total cell number, viable cell number, DNA content, and cell and nuclear morphology. The results of these analyses are summarized in Fig. [6](#F6){ref-type="fig"}. While wild-type cells continued to double approximately every 2 h and maintained ∼90% viability throughout the time course of the experiment, KGY1023 underwent about two and a half viable cell doublings during the first 5 h of the time course and then ceased to divide (Fig. [8](#F8){ref-type="fig"} *a*). Viability was maintained at ∼85% during the first 6 h of the time course and then began to decline. By 10 h after shift from SGR to SD, viability had fallen to 43% (Fig. [8](#F8){ref-type="fig"} *b*). The loss in viability was not associated with a homogenous arrest morphology. Even at the 10-h time point, KGY1023 consisted of a mixed population of unbudded cells, budded cells with an undivided nucleus, and budded cells with DNA divided between mother and daughter cells. Beginnning at the 4-h time point and throughout the remainder of the time course, however, a unique phenotype was observed. Approximately 10% of cells displayed a large budded phenotype with DNA positioned not at the mother bud neck but rather adjacent to the mother cell wall most distal to the daughter cell (data not shown). In addition, throughout the time course, the percentage of budded cells in KGY1023 was greater than that in KGY820 (data not shown). Consistent with the differential ratio of budded cells in the two populations, flow cytometric analysis revealed that, throughout the time course, the *cdh1*::HIS3 population contained 50 to 60% more cells with 2N DNA content than did the wild-type population (Fig. [8](#F8){ref-type="fig"}, *b* and *c*), suggesting that loss of CDH1 function resulted in accumulation of cells in the G~2~ and/or M phases of the cell cycle.

dim1 Displays only Weak Genetic Interactions with Mitotic Control Genes cdc2, cdc13, and cdr1
---------------------------------------------------------------------------------------------

*dim1*-35 was isolated as a second-site mutation capable of lowering the restrictive temperature of *cdc2*-D217N from 36° to 32°C. Furthermore, the *dim1*-35 and *cdh1*::HIS3 mutant phenotypes described above suggested a role for *dim1* in G~2~/M progression. Therefore, we wished to determine whether *dim1*-35 would show genetic interactions with various G~2~/M mutants, such as *cdc2*-22, *cdc13*-117, *cdc13*A382V, *cdc25*-22, and *cdr1*-76 (Table [I](#TI){ref-type="table"}). When double mutants were constructed, a lowering of restrictive temperature from 36° to 32°C again was observed. Upon more careful analysis, however, 32°C proved a semipermissive temperature for *dim1*-35 itself; the *dim1*-35 mutant streaked to 32°C formed small colonies of slow growing cells. At 29°C, a temperature fully permissive for *dim1*-35, all double mutants also proved viable (data not shown). Thus, *dim1*-35 did not display strong genetic interactions with other G~2~/M mutants. In addition to G~2~/M defects, *dim1*-35 also displayed characteristics reminiscent of mitotic mutants, including *cut* mutants, *dis* mutants, and *nda* mutants (see Introduction). As in the case of the G~2~/M mutants, however, double mutant construction and analysis revealed that *dim1*-35 exhibited no significant genetic interactions with *cut1*-205, *cut1*-RB5, *cut2*-364, *cut3*-447, *dis1*-288, or *nda3*km311 (data not shown; interaction with *nda2*-km52 could not be analyzed, as no temperature examined proved fully permissive for both the cold-sensitive *nda2*-km52 mutant and the temperature-sensitive *dim1*-35 mutant).

The dim1-35 Mutant Arrests with Low Histone H1 Kinase Activity
--------------------------------------------------------------

Because genetic analyses did not prove informative in probing the function of Dim1p, we decided to take a biochemical approach. We considered the possibility that the failure of *dim1*-35 to complete mitosis successfully may reflect an inability to attain or maintain levels of Cdc2p/ Cdc13p kinase activity sufficient to drive productive entry into and successful passage through mitosis. Indeed, as described above, the *dim1::his3* ^+^ mutant displayed reduced levels of histone H1 kinase activity as compared to a wildtype control. To determine whether Cdc13p-associated Cdc2p kinase activity was compromised in *dim1*-35 as well, protein lysates prepared from *dim1*-35 as well as from wild-type, *cdc25*-22, and *nuc2*-663 cells incubated at 36.5°C were subjected to immunoprecipitation using the polyclonal anti-Cdc13p antibody GJG56. Immunoprecipitates were assayed for histone H1 kinase activity. As illustrated in Fig. [9](#F9){ref-type="fig"}, H1 kinase activity in the *dim1*-35 mutant was comparable to that of *cdc25*-22, a temperature-sensitive mutant that arrests in G~2~, before entry into mitosis (Cdc2p/Cdc13p kinase activity low). The kinase activity of *dim1*-35 or of *cdc25*-22 was ∼50% that of wild-type cells and ∼25% that observed in the temperature-sensitive mutant *nuc2*-663, which arrests in mid-mitosis (Cdc2p/Cdc13p activity high). Thus, the *dim1*-35 mutant incubated at restrictive temperature contained low levels of Cdc13p-associated histone H1 kinase activity, although the level of Cdc2p/Cdc13p complex was not detectably lower (data not shown).

The dim1-35 Mutant Displays Sensitivity to the Microtubule Destabilizing Drug TBZ
---------------------------------------------------------------------------------

To investigate further the function of Dim1p, we chose to examine the sensitivity of *dim1*-35 to various drugs. In particular, the failure of nuclear division in those *dim1*-35 cells that leak into M phase suggested that the *dim1*-35 mutation may affect spindle function. Note that spindle formation and elongation in the *dim1*-35 mutant appeared normal (see above). Nevertheless, we considered the possibility that the *dim1*-35 mutation may affect spindle function indirectly, or in such a way as to prove undetectable at the level of resolution of light microscopy. Therefore, we tested *dim1*-35 for sensitivity to the microtubule destabilizing drug TBZ. The *dim1*-35 mutant did in fact prove sensitive to TBZ. At the permissive temperature of 29°C, *dim1*-35 cells were unable to form single colonies on YE agar containing 9 μg/ml TBZ, whereas wild-type cells were uninhibited in single colony formation by TBZ at this concentration (Fig. [10](#F10){ref-type="fig"} *a*). To determine the terminal phenotype of the *dim1*-35 mutant exposed to TBZ, wild-type or *dim1*-35 mutant cells were incubated at 29°C in YE medium containing 10 μg/ml TBZ. TAT1 immunofluorescence performed on fixed cells revealed that spindle formation and elongation did occur in *dim1*-35 under these conditions (data not shown). Nevertheless, 40% of *dim1*35 cells displayed a cut phenotype or gross missegregation of DNA; only 4% of wild-type cells displayed such phenotypes (Fig. [10](#F10){ref-type="fig"}, *b* and *c*).

Discussion
==========

We have identified a fission yeast gene, *dim1* ^+^, essential for entry into and progression through mitosis. Mutant cells deleted for the *dim1* coding region arrest in G~2~ with cytoplasmic microtubules and single interphase nuclei of 2C DNA content. The terminal phenotype of the *dim1* deletion mutant shows no evidence of entry into mitosis. In contrast, in the temperature-sensitive *dim1*-35 mutant, cells may enter mitosis at restrictive temperature. Specifically, in a synchronous population of *dim1*-35 cells shifted to restrictive temperature, 80% of cells divide at the first mitosis without significant loss of viability; 20% fail to divide. At the second mitosis, ∼50% of cells fail to divide. Of the 50% of cells that do progress through mitosis and cytokinesis, 70% cut or missegregate their DNA, as judged by DAPI staining. Consistent with the DAPI phenotype, cells of greater or less than 2C DNA content accumulate, and viability decreases significantly at the second round of septation. Loss of 2C DNA occurs subsequent to loss of viability, suggesting that cutting per se is not the lethal event. Rather, based upon the terminal phenotype of the *dim1* deletion mutant in conjunction with that of *dim1*-35, we conclude that (*a*) *dim1* gene function is required in late G~2~ for successful entry into and progression through M phase; and (*b*) *dim1*-35 represents a hypomorphic allele that blocks some cells at the *dim1* execution point before entry into mitosis but allows other cells to leak into M phase. Those cells that leak past the *dim1* block, however, are unable to complete mitosis successfully, due to previous failure of *dim1* function.

Not only is *dim1* gene function required for proper G~2~/M progression, but in the *dim1*-35 mutant at restrictive temperature, faithful DNA segregation is uncoupled from subsequent cell cycle events. That is to say, septation occurs in the absence of nuclear division. Moreover, after missegregation of DNA and subsequent septation, daughter cells that receive greater or less than a full chromosomal complement appear to enter S phase of the next cell cycle, resulting in accumulation of cells of greater than or less than 2C DNA content.

The behavior of the *dim1*-35 mutation in a *cdc11*-119 background supports our interpretation of data obtained in synchronous shift experiments. As in the *dim1*-35 single mutant, 20% of *cdc11*-119 *dim1*-35 double mutants shifted to restrictive temperature fail to undergo a first mitosis; 20% of cells remain uninucleate throughout the time course of the temperature shift experiment. The remaining 80% of cells complete mitosis of a first cell cycle and then arrest predominantly as binucleates. Although these cells do not block with features characteristic of midmitotic arrest (i.e., condensed chromosomes and/or presence of a mitotic spindle), evidence suggests mitotic defects in at least a subpopulation of cells. First, 20% of cells leak through the binucleate block to accumulate greater than two nuclei per cell by 6 to 7 h after shift. Of these, 50% contain three rather than four nuclei. In contrast, *cdc11*119 single mutant cells undergo synchronous rounds of mitosis such that cells always contain 2, 4, 8, or 16 nuclei. We hypothesize that *cdc11*-119 *dim1*-35 trinucleate cells arise when a binucleate leaks into M phase, but due to inadequate Dim1p function, only one of the two nuclei is able to complete mitosis successfully.

Additional evidence for "leaky" passage through M phase and subsequent progression through the cell cycle in a subpopulation of *cdc11*-119 *dim1*-35 double mutant cells lies in the accumulation of cells of 8C DNA content, despite almost complete stabilization of nuclear content at two nuclei per cell throughout the last 3 h of the time course. Such accumulation of DNA without a corresponding increase in number of nuclei per cell (i.e., without chromosomal segregation) has been observed previously in both *cdc11*-119 *top2* and *cdc11*-119 *cut1* double mutants ([@B65]; [@B69]). After shift to restrictive temperature, these mutants undergo multiple rounds of the cell cycle without nuclear division, such that the single nucleus in a *cdc11*-119 *cut1* double mutant cell accumulates multiple aberrant spindle pole bodies, as well as polyploid DNA content. The single nucleus in a *cdc11*119 *top2* double mutant cell accumulates greater than 2C DNA, but multiple SPBs are not observed.

The second cell cycle effect as well as the "leaky" nature of the *dim1*-35 mutation in either a *cdc11* ^+^ or *cdc11*-119 background suggests that *dim1*-35 represents a hypomorphic allele. An alternative explanation for the second cell cycle arrest observed in *dim1*-35 is that loss of *dim1* function in G~1~ or S results in failure to complete the subsequent mitosis. Thus, cells synchronized in early G~2~ and shifted to restrictive temperature would progress through a first round of mitosis and would arrest only at the second round of mitosis, after passing through G~1~/S in the absence of *dim1* function. Such a phenomenon is observed in the *S. cerevisiae* mutant *pds1*-1, in which an anaphase defect occurs as the result of a temperature-sensitive step in cell cycle progression which occurs between G~1~ and S ([@B71]). In an attempt to address the possibility of a role for *dim1* in G~1~ or S, we performed nitrogen starvation/release experiments and spore germination experiments. In these experiments, a first cell cycle arrest was observed. However, these experiments do not necessarily indicate a role for *dim1* in G~1~/S. Rather, given the hypomorphic nature of the *dim1*-35 allele, we consider it more likely that the first cell cycle arrest observed in the nitrogen starvation/release and spore germination experiments reflects the length of time spent at restrictive temperature before entry into M phase in these experiments: cells synchronized in early G~2~ enter a first round of M phase 85 min after shift to restrictive temperature; nitrogen-starved cells, 3.5 h after shift; and germinating spores, 7 h after shift (data not shown). Thus, we hypothesize that the weakly temperature-sensitive Dim1-35 protein remains functional through the first mitosis in synchronous shift experiments but has lost function by the time of the first mitosis in nitrogen starvation/release and spore germination experiments. This results in an apparent second cell cycle arrest in synchronous cultures but a first cell cycle arrest in nitrogen starvation/release and spore germination experiments.

Although a G~1~/S role for *dim1* remains a remote possibility, our results demonstrate that neither the *dim1*-35 mutation nor deletion of *dim1* from the genome blocks progression through S phase per se. In the synchronous shift experiments, cells continue to accumulate DNA despite cutting and/or missegregation of chromosomes; in the *cdc11*-119 *dim1*-35 double mutant, DNA replication is not impaired, despite failure of chromosome segregation; in both nitrogen starvation/release and spore germination experiments, cells accumulate 2C DNA at restrictive temperature; and, finally, both *chd1*::HIS3 and *dim1::his3* ^+^ mutants arrest with 2C DNA. It should be noted that certain S phase mutants are capable of bulk DNA replication, such that accumulation of a G~2~ content of DNA is not blocked at restrictive temperature ([@B42]; [@B12]; [@B30]; [@B36]). Because DNA replication is defective, however, these mutants arrest in G~2~ by virtue of invoking the DNA replication checkpoint. In a genetic background in which the checkpoint gene *rad1* is deleted, the DNA replication checkpoint is lost, and S phase mutants enter mitosis without having properly replicated their DNA, resulting in dramatic loss of viability ([@B1]). In contrast, *dim1*-35 in a *rad1::ura4* ^+^ background exhibits no increased frequency of cutting or loss of viability at restrictive temperature, as compared to *dim1*-35 in a *rad1* ^+^ background (data not shown). Therefore, *dim1*-35 mutant cells are capable not only of bulk DNA replication but of proper DNA replication, further supporting our conclusion that *dim1* does not play a role in S phase but rather functions in late G~2~ or early M.

Molecular cloning has provided little insight into the nature of Dim1p function. However, cloning has revealed a remarkable evolutionary conservation of Dim1p at the sequence level. Our studies further demonstrate conservation at the level of function: Both *S. pombe dim1* and mouse *dim1* are capable of rescuing a null allele of *S. cerevisiae* CDH1; *mdim1* functionally complements a null allele of *S. pombe dim1.* Analysis of the *S. cerevisiae cdh1*:: HIS3 mutant phenotype also suggests functional conservation of Dim1p, in that the accumulation of cells with 2C DNA content in *cdh1*::HIS3 indicates a possible role for Cdh1 protein in the G~2~/M transition.

The accumulation of *cdh1*::HIS3 cells with a G~2~/M content of DNA, taken together with our analyses of the *dim1::his3* ^+^ and *dim1*-35 mutant phenotypes, suggest a model for Dim1p function. We propose that Dim1p plays an essential role in reorganization of microtubules at mitosis and/or in reorganization of chromatin for attachment to the mitotic spindle. For proper segregation of DNA during mitosis, the cytoplasmic microtubule network must disassemble, the microtubule-based mitotic spindle must form, and condensed chromosomes must attach to the spindle. Both TBZ sensitivity and the DNA missegregation/cut phenotype of *dim1*-35 are consistent with defects in one or more of the above processes. Thus, *dim1::his3* ^+^ mutant cells arrest before entry into mitosis, in the absence of spindle formation or changes in chromatin structure. In contrast, in the hypomorphic *dim1*-35 mutant, some cells may block tightly before entry into mitosis, with an interphase array of microtubules, a single interphase nucleus (i.e., uncondensed chromosomes), and low histone H1 kinase activity. *dim1*-35 cells that leak into M phase form spindles, but spindle function and/or mitotic chromosome dynamics are compromised. Cells then proceed through mitosis in the absence of chromosome segregation, resulting in development of a cut phenotype or segregation of DNA to only one daughter cell.

Although septation in the absence of chromosome segregation in *dim1*-35 could suggest loss of a mitotic checkpoint, we do not imagine that *dim1* plays a role in checkpoint control. As discussed above, many fission yeast mitotic mutants uncouple mitotic processes. For example, the *cut* mutants undergo septation and cytokinesis without nuclear division; septation mutants undergo repeated rounds of S phase and mitosis without septation and cytokinesis; *cdc11 top2* and *cdc11 cut1* double mutants undergo repeated rounds of S phase and mitosis without nuclear division or septation and cytokinesis. It seems unlikely that all of these mutants define genes whose products function in checkpoint pathways. Rather, like *dim1*-35, these mutants demonstrate the separability of mitotic processes, both from each other and from subsequent cell cycle events.

To date, biochemical analyses have not proven informative in examining *dim1* function, primarily due to lack of effective reagents. Although polyclonal antibodies generated against recombinant Dim1p as well as anti-epitope antibodies used to analyze epitope-tagged versions of Dim1p, are adequate for Western blotting applications (data not shown), these antibodies are unable to immunoprecipitate Dim1p or to detect Dim1p by immunofluorescence. Thus, extensive biochemical analyses of Dim1p have not been possible. The generation of more effective reagents in addition to the isolation of new alleles of *dim1* as well as suppressors and enhancers of the *dim1*-35 mutant phenotype may allow us to examine Dim1p function in greater detail. Regardless of the precise molecular nature of Dim1p function, however, the work presented here demonstrates a fundamental, evolutionarily conserved role for *dim1* in G~2~/M progression as well as in chromosome segregation during mitosis.
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S. Pombe Strains Used in This Study

  Strain designation      Genotype                                                                                                                        Source
  -------------------- -- ---------------------------------------------------------------------------------------------------------------------------- -- ------------------------------------------------
  KGY28                   h- 972                                                                                                                          P. Nurse[\*](#TFI-150){ref-type="table-fn"}
  KGY56                   h^+^ *nda3*-km311 *leu1*-32                                                                                                     P. Nurse
  KGY69                   h^+^ 975                                                                                                                        P. Nurse
  KGY89                   h- *nda2*-km52 *leu1*-32                                                                                                        P. Nurse
  KGY90                   h- *dis1*-288 *leu1*-32                                                                                                         P. Nurse
  KGY107                  h- *cdc11*-119                                                                                                                  P. Nurse
  KGY155                  h^+^ *cdc25*-22                                                                                                                 P. Nurse
  KGY246                  h- *ura4*-D18 *leu1*-32 *ade6*-M210                                                                                             P. Nurse
  KGY247                  h^+^ *ura4*-D18 *leu1*-32 *ade6*-M210                                                                                           P. Nurse
  KGY248                  h- *ura4*-D18 *leu1*-32 *ade6*-M216                                                                                             P. Nurse
  KGY249                  h^+^ *ura4*-D18 *leu1*-32 *ade6*-M216                                                                                           P. Nurse
  KGY384                  h^+^ *dim1*-35 cdc25-22                                                                                                         This study
  KGY387                  h- *dim1*-35 *dis1*-288                                                                                                         This study
  KGY392                  h^+^ *dim1*-35                                                                                                                  This study
  KGY394                  h^+^ *dim1*-35 *ade6*-M216                                                                                                      This study
  KGY396                  h^+^ *dim1*-35 *leu1*-32                                                                                                        This study
  KGY402                  h- *dim1*-35                                                                                                                    This study
  KGY455                  h- *cdc2*-D217N *ura4*-D18 *leu1*-32 *ade6*-M210                                                                                [@B7]
  KGY490                  h- *dim1*-35 *ura4*-D18                                                                                                         This study
  KGY517                  h^+^ *rad1::ura4* ^+^ *ura4*-D18 *leu1*-32                                                                                      S. Subramani[‡](#TFI-152){ref-type="table-fn"}
  KGY533                  h- *cdc2*-22 *leu1*-32 *ura4*-D18 *ade6*-M216                                                                                   P. Nurse
  KGY557                  h- *dim1*-35 *ade6*-M210                                                                                                        This study
  KGY621                  h- *cdc13*-A381V *his3*-237 *ura4*-D18 *leu1*-32 *ade6*-M210                                                                    [@B7]
  KGY698                  h^+^ *dim1*-35 *his3*-237 *ura4*-D18 leu1-32 *ade6*-M210                                                                        This study
  KGY833                  h^+^/h- *dim1*-35/*dim1::ura4* ^+^ *his3-237/his3* ^+^ *ura4*-*D18*/*ura4*-*D18 leu1*-32/*leu1*-32 *ade6*-M210/*ade6*-M216      This study
  KGY838                  h- *cdr1*-76 *leu1*-32 *ade6*-M216                                                                                              [@B74]
  KGY841                  h^+/^h- *dim1* ^+^/*dim1::ura*4^+^ *his3-237/his3* ^+^ *ura4*-D18/*ura4*-D18 *leu1*-32/*leu1*-32 *ade6*-M210/*ade6*-M216        This study
  KGY842                  h^+^ *dim1::ura4* ^+^ carrying pKG709 *ura4*-D18 *leu1*-32 *ade6*-M216                                                          This study
  KGY843                  h- *cdc13*-117 *ura4*-D18 *leu1*-32 *ade6*-M210                                                                                 P. Nurse
  KGY858                  h^+^ *dim1::ura4* ^+^ carrying pKG718 *ura4*-D18 *leu1*-32 *ade6*-M216                                                          This study
  KGY872                  h- *cdc25*-22 *dim1*-35 *his3*-D1 *ura4*-D18 *leu1*-32 *ade6*-M210                                                              This study
  KGY874                  h^+^ *cdc13*-117 *dim1*-35 *ura4*-D18 *leu1*-32 *ade6*-M210                                                                     This study
  KGY878                  h- *cdc2*-22 *dim1*-35                                                                                                          This study
  KGY879                  h- *dim1*-35 *cdc*13-A381V                                                                                                      This study
  KGY895                  h- *dim1*-35 *cdr1*-76                                                                                                          This study
  KGY896                  h- *cdc2*-D217N *dim1*-35                                                                                                       This study
  KGY939                  h- *cut1*-RB5 *ura4*-D18 *leu1*-32                                                                                              I. Hagan[§](#TFI-153){ref-type="table-fn"}
  KGY942                  h^+^ *cdc11*-119 *dim1*-35                                                                                                      This study
  KGY943                  h- *cut1*-RB5 *dim1*-35 *leu1*-32                                                                                               This study
  KGY957                  h^+^ *cut3*-477                                                                                                                 R. McIntosh[‖](#TFI-155){ref-type="table-fn"}
  KGY958                  h- *cut1*-205 *leu1*-32                                                                                                         R. McIntosh
  KGY982                  h^+^ nuc2-663 *leu1*-32 *ura4*-D18 *ade6*-M210 h^+^                                                                             P. Nurse
  KGY1019                 h- *cut2*-364 *leu1*-32                                                                                                         R. McIntosh
  KGY1020                 h- *cut2*-205 *dim1*-35                                                                                                         This study
  KGY1021                 h- *cut2*-364 *dim1*-35                                                                                                         This study
  KGY1022                 h-*dim1*-35 *rad1*::*ura4* ^+^ *ura4*-D18                                                                                       This study
  KGY1028                 h^+^/h- *dim1*-35/*dim1* ^+^ *his3*-D1/*his3*-D1 *ura4*-D18/*ura4*-D18 *leu1*-32/*leu1*-32 *ade6*-M210/*ade6*-M216              This study
  KGY1087                 h^+^/h- *dim1*-35/*dim1::his3* ^+^ *his3*-D1/*his3*-D1 *ura4*-D18/*ura4*-D18 *leu1*-32/*leu1*-32 *ade6*-M210/*ade6*-M216        This study
  KGY1088                 h^+^/h- *dim1::his3* ^+^ */dim1* ^+^ *his3*-D1/*his3*-D1 *ura4*-D18/*ura4*-D18 *leu1*-32/*leu1*-32 *ade6*-M210/*ade6*-M216      This study
  KGY1089                 h- *dim1::his3* ^+^ carrying pKG897 *his3*-D1 *ura4*-D18 *leu1*-32 *ade6*-M210                                                  This study
  KGY1090                 h^+^ *dim1::his3* ^+^ carrying pKG898 *his3*-D1 *ura4*-D18 *leu1*-32 *ade6*-M210                                                This study
  KGY1091                 h^+^ *dim1::ura4* ^+^ carrying pKG815 *ura4*-D18 *leu1*-32 *ade6*-M216                                                          This study
  KGY1092                 h^+^ *dim1::ura4* ^+^ carrying pKG930 *ura4*-D18 *leu1*-32 *ade6*-M210                                                          This study
  KGY1115                 h- *leu1*-32::pKG984                                                                                                            This study
  KGY1124                 h- *dim1*-35 *leu1*-32::pKG984                                                                                                  This study
  KGY1138                 h- dim1-35::pKG695 ura4-D18 *leu1*-32 ade6-M210                                                                                 This study
  KGY1139                 h^+^ *dim1*-35::pKG695 *ura4*-D18 *leu1*-32 *ade6*-M210                                                                         This study
  KGY1155                 h- *nda3*-km311 *dim1*-35 leu1-32                                                                                               This study
  KGY1156                 h-*cut3*-447 *dim1*-35                                                                                                          This study
  KGY1180                 h^+^ *dim1::his3* ^+^ *leu1-32::*p980 *his3*-D1 *ura4*-D18 *ade6*-M210                                                          This study
  KGY1216                 h^+^ *leu1*-32::0980 *ura4*-D18 *ade6*-M210                                                                                     This study
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S. cerevisiae Strains Used in This Study

  Strain designation      Genotype                                                                                                     Source
  -------------------- -- --------------------------------------------------------------------------------------------------------- -- ------------
  KGY311                  MATα *cdh1*::HIS3 *leu2*-3, 112::pKG914 *ura3*-52 *his3*-d200 *trp1*-d901, *suc2*-D9, *lys2*-801             This study
  KGY572                  MATα *cdh1*::HIS3 *leu2*-3, 112::pKG913 *ura3*-52 *his3*-D200 *trp1*-D901, *suc2*-D9, *lys2*-801             This study
  KGY820                  MATα *his3*-d200 *leu2*-3, 112 *lys2*-801 *ura3*-52 *trp1*-d901 *suc2*-d9                                    T. Graham
  KGY821                  MATα *his3*-d200 *leu2*-3, 112 *ade2*-101 *ura3*-52 *trp1*-d901 *suc2*-d9                                    T. Graham
  KGY823                  MATα/MATa *his3*-d200/*his3*-d200 *leu2*-3, 112/*leu2*-3, 112 *leu2*-801/+*ade2*-101/+ *ura3*-52/            T. Graham
                            *ura3*-52 *trp1*-d901/*trp1*-d901 *suc2*-d9/*suc2*-d9                                                      
  KGY937                  MATα/MATa CDH1/*cdh1*::HIS3 *his3*-d200/ *his3*-d200 *leu2*-3, 112/ *leu2*-3, 112 *lys2*-801/+               This study
                            *ade2*-101/1 *ura3*-52/*ura3*-52 *trp1*-d901/*trp1*-d901 *suc2*-d9/*suc2*-d9                               
  KGY965                  MATα *cdh1*::HIS3 *leu2*-3,112::pKG912 *ura3*-52 *his3*-D200 *trp1*-D901, *suc2*-D9, *lys2*-801              This study
  KGY966                  MATα *cdh1*::HIS3 *leu2*-3,112::pKG911 *ura3*-52 *his3*-D200 *trp1*-D901, *suc2*-D9, *lys2*-801              This study
  KGY1023                 MATα *cdh1*::HIS3 *leu2*-3,112::pKG903 *ura3*-52 *his3*-D200 *trp1*-D901, *suc2*-D9, *lys2*-801              This study
  KGY1026                 MATα *cdh1*::HIS3 *leu2*-3,112::pKG882 *ura3*-52 *his3*-D200 *trp1*-D901, *suc2*-D9, *lys2*-801              This study
  KGY1093                 MATα *cdh1*::HIS3 carrying pKG900 *leu2*-3,112 *ura3*-52 *his3*-D200 *trp1*-D901, *suc2*-D9, *lys2*-801      This study

###### 

Plasmids Constructed in This Study

  Plasmid      Parent vector      Insert
  --------- -- --------------- -- -------------------------------------------------------------------------------
  pKG402       pREP41             *dim1* ^+^ *cDNA*
  pKG681       pUR19              *dim1 3.7 kb genomic fragment*
  pKG683       pUR19              *dim1 2 kb genomic fragment*
  pKG695       pJK210             *dim1 3.7 kb genomic fragment*
  pKG703       pBS-SK^+^          *dim1*::*ura4* ^+^ (1 kb *dim1* 5′ flank::*ura4* ^+^::1.2 kb *dim1* 3′ flank)
  pKG709       pMNS21L            *dim1* ^+^ cDNA
  pKG718       pRHA41             *dim1* ^+^ cDNA
  pKG745       pMNS21L            *dim1*-35 genomic PCR product
  pKG815       pREP81             *dim1* ^+^ cDNA
  pKG836       pMNS21L            CDH1 cDNA
  pKG837       pRS415GALS         CDH1 cDNA
  pKG843       pRS415GALS         *dim1* ^+^ cDNA
  pKG849       pRS415MET25        CDH1 cDNA
  pKG850       pRS415MET25        *dim1* ^+^ cDNA
  pKG872       pBS-SK+            N-degron/Ubiquitin tag
  pKG875       pRS415GALS         UBCDH1 cDNA
  pKG876       pRS415GALS         UB*dim1* ^+^ cDNA
  pKG882       pRS405             GALS::UBCDH1 cDNA
  pKG889       pREP81             CDH1 cDNA
  pKG894       pREP41             CDH1 cDNA
  pKG897       pREP42             *dim1* ^+^ cDNA
  pKG898       pREP82             *dim1* ^+^ cDNA
  pKG900       pRS415GALS         *mdim1* cDNA
  pKG901       pREP81             *mdim1* cDNA
  pKG903       pRS405             GALS::UB*dim1* ^+^ cDNA
  pKG911       pRS405             MET25::*dim1* ^+^ cDNA
  pKG912       pRS405             GALS::CDH1 cDNA
  pKG913       pRS405             MET25::CDH1 cDNA
  pKG914       pRS405             GALS::*dim1* ^+^ cDNA
  pKG916       pBS-SK^+^          *dim1::Hind*III (1 kb *dim1* 5*′* flank::*Hind*IIIsite::1.2 kb 3′ flank)
  pKG917       pBS-SK^+^          *dim1::his3* ^+^ (1 kb *dim1* 5′ flank::*his3* ^+^::1.2 kb 3′ flank)
  pKG930       pREP1              *mdim1* cDNA
  pKG931       pREP81             *mdim1* cDNA
  pKG980       pJK148             *nmtl*-T81::*dim1* ^+^ cDNA
  pKG984       pJK148             *nmtl*::CDH1 cDNA

###### 

Upon release from nitrogen starvation, *dim1*-35 cells incubated at restrictive temperature accumulate 2C DNA but display first cell cycle arrest at or just before entry into mitosis. *dim1*-35 cells were starved for nitrogen at permissive temperature and then shifted to rich medium at restrictive temperature. Samples were collected for analysis at 30-min intervals. (*a*) DNA content of *dim1*-35 cells after shift. (*b*) Viability (○), 2C DNA content (□), and septation index (•) of *dim1*-35 cells after shift. Note that viability remains high until the majority of cells have completed S phase (i.e., accumulated 2C DNA) and then begins to decline ∼4 h into the time course, just before septated cells are first observed (at *t* = 4.5 h). (*c*) Cut phenotype of septated cells at *t* = 5 h. Bar, 5 μm.
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###### 

A synchronized population of *dim1*-35 mutant cells shifted to restrictive temperature displays a second cell cycle arrest. *dim1*-35 mutant (KGY392) or wildtype (KGY28) cells were grown to midlog phase in rich medium at permissive temperature (25°C). Cells were synchronized in early G~2~ by centrifugal elutriation and then inoculated into rich medium at 36.5°C. Samples were collected at 20- to 25min intervals and subjected to various analyses. (*a*) DNA content of *dim1*-35 mutant cells after shift to restrictive temperature. Cells were fixed with ethanol, stained with propidium iodide, and subjected to flow cytometric analysis. DNA content, expressed in arbitrary units, is shown on the horizontal axis. Cell number is shown on the vertical axis. (*b*) Cell and nuclear morphology of *dim1*-35 cells at the first peak of septation (*top*), at the second peak of septation (*middle*), and after the second round of septation (*bottom*). Cells were fixed with ethanol and stained with DAPI. Arrowheads indicate septa. (*c*) Septation index of *dim1*-35 (○) or wild type (•) cells after shift. (*d*) Percent viability (○), percentage of cells containing 2C DNA (▵), and septation index (□) of *dim1*-35 mutant cells after shift. Note that viability begins to decline sharply at *t* = 230 min, just before septated cells are first observed at *t* = 250 min. (*e*) Tubulin and SPB staining of *dim1*-35 mutant cells at second peak of septation after shift to restrictive temperature. (*Left*) DNA stained with DAPI. (*Middle)* Tubulin stained with TAT1 antibody. *(Right*) SPBs stained with α-Sad1p antibody. Note that septation has occurred, bisecting the elongated spindle and producing two daughter cells, one containing the undivided nucleus (\*) and one containing no chromatin (\*\*). Arrowheads indicate septa; arrows indicate SPBs. Bars: (*b*) 5 μm; (*e*) 3 μm.
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###### 

*cdc11*-119 *dim1*-35 double mutants shifted to restrictive temperature arrest primarily as binucleates. *cdc11*-119 (KGY107) or *cdc11*-119 *dim1*-35 (KGY942) mutant cells were grown to midlog phase in rich medium at 25°C and then shifted to 37°C. Samples were taken at hourly intervals to monitor progression through the cell cycle after shift. (*a*) Cell and nuclear morphology of *cdc11*-119 (*left*) or *cdc11*-119 *dim1*-35 (*right*) 6 h after shift. Cells were fixed with ethanol and stained with DAPI. (*b*) Nuclear content of *cdc11*119 (*left*) or *cdc11*-119 *dim1*35 (*right*) after shift. Horizontal axis shows time after shift. Vertical axis shows percent of cells containing one nucleus (□), two nuclei (▵), three or four nuclei (for *cdc11*-119 *dim1*-35; ○), four nuclei (for *cdc11*-119, ○), or 8 nuclei (▪). (*c*) DNA content of *cdc11*-119 (*left*) or *cdc11*-119 *dim1*-35 (*right*) after shift. Horizontal axis shows time after shift. Vertical axis shows percent of cells containing 2C DNA (□), 4C DNA (▵), or 8C DNA (○). (*d*) Cell and nuclear morphology of *cdc11*-119 (*left*) or *cdc11*-119 *dim1*-35 (*right*) 5 h after shift. (*Top*) DNA stained with DAPI. (*Middle*) Tubulin stained with the monoclonal antibody TAT1. (*Bottom*) SPBs stained with polyclonal α-Sad1p antibodies. (*e*) Flow cytometric analysis of *cdc11*-119 (*left*) or *cdc11*-119 *dim1*-35 (*right*) after shift. Note that DNA content data for *cdc11*-119 at the 7 h time point were not collected, as most cells had accumulated \>8C DNA. (*f*) *cdc11*-119 *dim1*-35, 6 h after shift, showing trinucleate phenotype. Note that this phenotype occurred in only 10% of cells at the 6-h time point. Bars: (*a*) 10 μm; (*d*) 5 μm; (*f*) 5 μm.
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###### 

Cloning of *dim1.* (*a*) Restriction map of *dim1* genomic locus and identification of minimal rescuing fragment. □, *dim1* exon; H, *Hinc*II; S, *Sac*1; X, *Xba*1; E, *Eco*RV; C, *Cla*I. (*b*) Sequence of minimal rescuing fragment, showing putative coding region, intron/exon structure, and coding potential. Consensus 5′ splice, 3′ splice, and branch site sequences are underlined. The nucleotide and amino acid altered in *dim1*-35 are indicated in bold. These sequence data are available from GenBank/EMBL/ DDBJ under accession number AF001214. (*c*) Alignment of *S. pombe* Dim1p and putative Dim1 homologs. *Mus musculus*, *S. cerevisiase*, and partial *Homo sapiens* cDNAs were obtained and sequenced. The remaining cDNAs represent ESTs available in the databases. For any given Dim1p homolog, only those residues not identical to the corresponding residue in *S. pombe* Dim1p are indicated by a one letter amino acid code. Conserved residues are indicated by a dash (--). Note that the *Arabidopsis thaliana*, *Orzia sativa*, and *H. sapiens* sequences are incomplete. Blank spaces indicate unknown sequence or stretches of sequence in which a frame shift, likely due to error in the available sequence, results in loss of homology or introduction of a nonsense mutation. Of the full length clones sequenced in this lab, *S. pombe* and *M. musculus dim1* share 79% identity at the amino acid level; *S. pombe* and *S. cerevisiae*, 65% identity; and *M. musculus* and *S. cerevisiae*, 64% identity.

![](JCB.32738f4a)

![](JCB.32738f4b)

###### 

Deletion of the *dim1* coding region from the *S. pombe* genome. (*a*) Schematic showing replacement of entire *dim1* coding region with the *ura4* ^+^ or *his3* ^+^ selectable marker. (*b*) Tetrad dissected from sporulated KGY833 diploid cell, germinated at 25°C. Viable colonies (*first* and *third images*) were Ura^−^Dim1^ts^. Inviable cells (presumed *dim1::ura4* ^+^; *second* and *fourth images*) divided once and then arrested. (*c*) Rescue of *dim1::ura4* ^+^ by *dim1* ^+^ and *mdim1.* Cells were streaked to minimal medium either lacking (*middle*) or containing (*right*) thiamine and then incubated at 32°C for 3 d. (*Left*) *dim1::ura4* ^+^ carrying: (*1*) *nmt1-T81:: dim1* ^+^ (KGY1091), (*2*) *nmt1-*T4*::dim1* ^+^ (KGY858), (*3*) *nmt1:: dim1* ^+^ (KGY842), and (*4*) *nmt1::mdim1* (KGY1092). (*d* and *e*) Rescue of *dim1::ura4* ^+^ by *nmt1::dim1* ^+^ (*d*) or *nmt1::mdim1* (*e*). KGY842 (*d*) or KGY1092 (*e*) was grown to midlog phase in minimal medium lacking thiamine, fixed with ethanol, and stained with DAPI. Bar, 10 μm.
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###### 

*dim1::his3* ^+^ mutant cells arrest in G~2~. *dim1::his3* ^+^ or *dim1* ^+^ cells carrying a single integrated copy of *nmt1−*T81:: *dim1* ^+^ (KGY1180 or KGY1216, respectively) were grown in minimal medium lacking thiamine and then shifted to rich medium containing thiamine to repress expression of the *nmt1-*T81:: *dim1* ^+^ cassette. Samples were collected for analysis at 1-h intervals after shift. (*a*) KGY1180 (□) and KGY1216 (•) total cell number after shift to rich medium. (*b*) KGY1180 DNA content after shift to rich medium. (*c* and *d*) DAPI (*c*) and corresponding tubulin (*d*) staining of KGY1180 cells 13 h after shift.
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![Deletion of CDH1 from the *S. cerevisiae* genome. (*a*) Cells were streaked to synthetic complete medium containing 1% galactose/1% raffinose (*middle*) or 2% glucose (*right*) and then incubated at 32°C for 2 d. (*Left*) *cdh1*::HIS 3 carrying: (*1*) MET25::CDH1 (KGY 572); (*2*) GALS::CDH1 (KGY965); (*3*) GALS::UBCDH1 (KGY1026); (*4*) MET25::*dim1* ^+^ (KGY966); (*5*) GALS::*dim1* ^+^ (KGY311); (*6*) GALS::UB*dim1* ^+^(KGY1023); (*7*) GALS::*mdim1* (KGY1093). (*b--d*) Rescue of *cdh1*::HIS3 by GALS::CDH1 (*b*), GALS::dim1^+^ (*c*), or GALS::*mdim1* (*d*). KGY 965 (*b*), KGY311 (*c*), or KGY1093 (*d*) was grown to midlog phase in SGR, fixed with ethanol, and stained with DAPI. Bar, 10 μM.](JCB.32738f7){#F7}

![Phenotype of the *cdh1*::HIS3 mutant. (*a*) Growth of *cdh1*:: HIS3 GALS::UB*dim1* ^+^ (KGY1023), and wild type (KGY820) after shift from SGR to SD. ▪, KGY820 total cell number; □, KGY820 viable cell number; •, KGY1023 total cell number; ○, KGY1023 viable cell number. (*b*) KGY1023 and KGY820 percent viability and percent of cells containing 2C DNA after shift from SGR to SD. □, KGY820 viability; ○, KGY1023 viability; ▪, KGY820 2C DNA; •, KGY1023 2C DNA. (*c*) Flow cytometric analysis showing DNA content of KGY820 (*left*) and KGY1023 (*right*) after shift from SGR to SD.](JCB.32738f8){#F8}

![Relative histone H1 kinase activity in wild-type or temperature-sensitive mutant strains. Strains were grown to midlog phase at 25°C in YE medium and then shifted to 36.5°C for 4.5 h. Cells were collected and lysed. Lysates were subjected to immunoprecipitation using α-Cdc13p antibodies. Immunoprecipitates were assayed for histone H1 kinase activity and Cdc2 protein levels. Relative histone H1 kinase activity is expressed in arbitrary units as detectable histone H1 phosphorylation normalized to corresponding Cdc2p level.](JCB.32738f9){#F9}

![TBZ sensitivity of *dim1*-35. (*a*) Wild-type (KGY28) or *dim1*-35 (KGY392) cells were streaked to YE agar containing 9 μg/ml TBZ dissolved in DMSO (*right*) or an equivalent amount of DMSO alone (*left*) and then incubated at 29°C for 3 d. (*b* and *c*) Phenotype of wild type cells (*b*) or *dim1*-35 cells (*c*) grown at 29°C for 6 h in YE medium containing 10 μg/ml TBZ. Cells were fixed with ethanol and stained with DAPI. Bar, 5 μm.](JCB.32738f10){#F10}
